The study investigates the relationship between longitudinal changes in oxygen extraction fraction (OEF) and remyelination in acute multiple sclerosis (MS) lesions. Twenty-two MS patients with 68 new gadolinium-enhancing lesions underwent MRI scans at baseline, 3 months, and 12 months. OEF was quantified using QQ, an integrative model combining quantitative susceptibility mapping (QSM) and quantitative blood oxygen level-dependent (qBOLD), while myelin content was measured by myelin water fraction using FAST-T2 imaging. A linear mixed-effect model assessed longitudinal changes in OEF and MWF and their associations. Both OEF and MWF significantly increased from baseline to 3 months (OEF: 20.1% ± 8.6%–25.0% ± 6.0%, p < 0.05 and MWF: 7.6% ± 2.5%–8.4% ± 2.8%, p < 0.05) but remained stable between 3 months and 12 months. A significant positive association was observed between changes in OEF and MWF from baseline to 3 months ( = 0.0768, p = 0.007). These findings suggest that early increase in OEF may reflect the metabolic demands of remyelination in acute MS lesions. This study highlights QQ’s potential to enhance our understanding of oxygen metabolism-related mechanism underlying remyelination.
ChariDM.Remyelination in multiple sclerosis. Int Rev Neurobiol2007; 79: 589–620.
10.
HarlowDEHonceJMMiravalleAA.Remyelination therapy in multiple sclerosis. Front Neurol2015; 6: 257.
11.
ZhouYZhangJ.Neuronal activity and remyelination: new insights into the molecular mechanisms and therapeutic advancements. Front Cell Dev Biol2023; 11: 1221890.
12.
TepavčevićV.Oligodendroglial energy metabolism and (re)myelination. Life2021; 11: 238.
13.
López-MuguruzaEMatuteC.Alterations of oligodendrocyte and myelin energy metabolism in multiple sclerosis. Int J Mol Sci2023; 24: 12912.
14.
LangleyMRTripletEMScarisbrickIA.Dietary influence on central nervous system myelin production, injury, and regeneration. Biochim Biophys Acta2020; 1866: 165779.
15.
SteinerJMartins-de-SouzaDSchiltzK, et al. Clozapine promotes glycolysis and myelin lipid synthesis in cultured oligodendrocytes. Front Cell Neurosci2014; 8: 384.
16.
ParkSJChoiJW.Brain energy metabolism and multiple sclerosis: progress and prospects. Arch Pharm Res2020; 43: 1017–1030.
17.
Sánchez-AbarcaLITaberneroAMedinaJM.Oligodendrocytes use lactate as a source of energy and as a precursor of lipids. Glia2001; 36: 321–329.
18.
LuntSYVander HeidenMG.Aerobic glycolysis: meeting the metabolic requirements of cell proliferation. Annu Rev Cell Dev Biol2011; 27: 441–464.
19.
RoneMBCuiQ-LFangJ, et al. Oligodendrogliopathy in multiple sclerosis: low glycolytic metabolic rate promotes oligodendrocyte survival. J Neurosci2016; 36: 4698–4707.
BiondettiEChoJLeeH.Cerebral oxygen metabolism from MRI susceptibility. Neuroimage2023; 276: 120189.
22.
JiangDLinZLiuP, et al. Brain oxygen extraction is differentially altered by Alzheimer’s and vascular diseases. J Magn Reson Imaging2020; 52: 1829–1837.
23.
ThomasBPShengMTsengBY, et al. Reduced global brain metabolism but maintained vascular function in amnestic mild cognitive impairment. J Cereb Blood Flow Metab2017; 37: 1508–1516.
24.
StadlbauerAZimmermannMKitzwögererM, et al. MR imaging-derived oxygen metabolism and neovascularization characterization for grading and IDH gene mutation detection of gliomas. Radiology2017; 283: 799–809.
25.
MaYMazerolleELChoJ, et al. Quantification of brain oxygen extraction fraction using QSM and a hyperoxic challenge. Magn Reson Med2020; 84: 3271–3285.
26.
ChoJKeeYSpincemailleP, et al. Cerebral metabolic rate of oxygen (CMRO2) mapping by combining quantitative susceptibility mapping (QSM) and quantitative blood oxygenation level-dependent imaging (qBOLD). Magn Reson Med2018; 80: 1595–1604.
27.
ChoJZhangSKeeY, et al. Cluster analysis of time evolution (CAT) for quantitative susceptibility mapping (QSM) and quantitative blood oxygen level-dependent magnitude (qBOLD)-based oxygen extraction fraction (OEF) and cerebral metabolic rate of oxygen (CMRO2) mapping. Magn Reson Med2020; 83: 844–857.
28.
ChoJSpincemaillePNguyenTD, et al. Temporal clustering, tissue composition, and total variation for mapping oxygen extraction fraction using QSM and quantitative BOLD. Magn Reson Med2021; 86: 2635–2646.
29.
ChoJZhangJSpincemailleP, et al. QQ-NET-using deep learning to solve quantitative susceptibility mapping and quantitative blood oxygen level dependent magnitude (QSM + qBOLD or QQ) based oxygen extraction fraction (OEF) mapping. Magn Reson Med2022; 87: 1583–1594.
30.
ChoJZhangJSpincemailleP, et al. Multi-echo complex quantitative susceptibility mapping and quantitative blood oxygen level-dependent magnitude (mcQSM + qBOLD or mcQQ) for oxygen extraction fraction (OEF) mapping. Bioengineering2024; 11: 131.
31.
HubertusSThomasSChoJ, et al. Comparison of gradient echo and gradient echo sampling of spin echo sequence for the quantification of the oxygen extraction fraction from a combined quantitative susceptibility mapping and quantitative BOLD (QSM + qBOLD) approach. Magn Reson Med2019; 82: 1491–1503.
32.
HubertusSThomasSChoJ, et al. Using an artificial neural network for fast mapping of the oxygen extraction fraction with combined QSM and quantitative BOLD. Magn Reson Med2019; 82: 2199–2211.
33.
MaYSunHChoJ, et al. Cerebral OEF quantification: a comparison study between quantitative susceptibility mapping and dual-gas calibrated BOLD imaging. Magn Reson Med2020; 83: 68–82.
34.
YablonskiyDASukstanskiiALHeX.Blood oxygenation level-dependent (BOLD)-based techniques for the quantification of brain hemodynamic and metabolic properties—theoretical models and experimental approaches. NMR Biomed2013; 26: 963–986.
35.
WangXSukstanskiiALYablonskiyDA.Optimization strategies for evaluation of brain hemodynamic parameters with qBOLD technique. Magn Reson Med2013; 69: 1034–1043.
36.
LeendersKLPeraniDLammertsmaAA, et al. Cerebral blood flow, blood volume and oxygen utilization: normal values and effect of age. Brain1990; 113: 27–47.
37.
ChoJMaYSpincemailleP, et al. Cerebral oxygen extraction fraction: comparison of dual-gas challenge calibrated BOLD with CBF and challenge-free gradient echo QSM + qBOLD. Magn Reson Med2021; 85: 953–961.
38.
ChoJLeeJAnH, et al. Cerebral oxygen extraction fraction (OEF): comparison of challenge-free gradient echo QSM + qBOLD (QQ) with 15O PET in healthy adults. J Cereb Blood Flow Metab2021; 41: 1658–1668.
39.
ChiangGCChoJDykeJ, et al. Brain oxygen extraction and neural tissue susceptibility are associated with cognitive impairment in older individuals. J Neuroimaging2022; 32: 697–709.
40.
YanSLuJLiY, et al. Spatiotemporal patterns of brain iron-oxygen metabolism in patients with Parkinson’s disease. Eur Radiol2024; 34: 3074–3083.
41.
ZhangSChoJNguyenTD, et al. Initial experience of challenge-free MRI-based oxygen extraction fraction mapping of ischemic stroke at various stages: comparison with perfusion and diffusion mapping. Front Neurosci2020; 14: 535441.
42.
WuDZhouYChoJ, et al. The spatiotemporal evolution of MRI-derived oxygen extraction fraction and perfusion in ischemic stroke. Front Neurosci2021; 15: 716031.
43.
ChoJNguyenTDHuangW, et al. Brain oxygen extraction fraction mapping in patients with multiple sclerosis. J Cereb Blood Flow Metab2022; 42: 338–348.
44.
XieYZhangSWuD, et al. The changes of oxygen extraction fraction in different types of lesions in relapsing–remitting multiple sclerosis: a cross-sectional and longitudinal study. Neurol Sci2024; 45: 3939–3949.
45.
YangLChoJChenT, et al. Oxygen extraction fraction (OEF) assesses cerebral oxygen metabolism of deep gray matter in patients with pre-eclampsia. Eur Radiol2022; 32: 6058–6069.
46.
ZhangQSuiCChoJ, et al. Assessing cerebral oxygen metabolism changes in patients with preeclampsia using voxel-based morphometry of oxygen extraction fraction maps in magnetic resonance imaging. Korean J Radiol2023; 24: 324.
47.
ZhuangHChoJChiangGC-Y, et al. Cerebral oxygen extraction fraction declines with ventricular enlargement in patients with normal pressure hydrocephalus. Clin Imaging2023; 97: 22–27.
48.
ShenNZhangSChoJ, et al. Application of cluster analysis of time evolution for magnetic resonance imaging-derived oxygen extraction fraction mapping: a promising strategy for the genetic profile prediction and grading of glioma. Front Neurosci2021; 15: 736891.
49.
van GrinsvenEEde LeeuwJSieroJCW, et al. Evaluating physiological MRI parameters in patients with brain metastases undergoing stereotactic radiosurgery—a preliminary analysis and case report. Cancers2023; 15: 4298.
50.
ElanghovanPNguyenTSpincemailleP, et al. Sensitivity assessment of QSM + qBOLD (or QQ) in detecting elevated oxygen extraction fraction (OEF) in physiological change. J Cereb Blood Flow Metab2025; 45: 735–745.
51.
WuDLiYZhangS, et al. Trajectories and sex differences of brain structure, oxygenation and perfusion functions in normal aging. Neuroimage2024; 302: 120903.
52.
LiuTWisnieffCLouM, et al. Nonlinear formulation of the magnetic field to source relationship for robust quantitative susceptibility mapping. Magn Reson Med2013; 69: 467–476.
53.
LiuTKhalidovIde RochefortL, et al. A novel background field removal method for MRI using projection onto dipole fields (PDF). NMR Biomed2011; 24: 1129–1136.
54.
LiuZSpincemaillePYaoY, et al. MEDI + 0: morphology enabled dipole inversion with automatic uniform cerebrospinal fluid zero reference for quantitative susceptibility mapping. Magn Reson Med2018; 79: 2795–2803.
55.
KeeYLiuZZhouL, et al. Quantitative susceptibility mapping (QSM) algorithms: mathematical rationale and computational implementations. IEEE Trans Biomed Eng2017; 64: 2531–2545.
56.
QSM Consensus Organization Committee, BilgicBCostagliM, et al. Recommended implementation of quantitative susceptibility mapping for clinical research in the brain: a consensus of the ISMRM electro-magnetic tissue properties study group. Magn Reson Med2024; 91: 1834–1862.
57.
FangJBaoLLiX, et al. Background field removal using a region adaptive kernel for quantitative susceptibility mapping of human brain. J Magn Reson2017; 281: 130–140.
58.
ZhangJChoJZhouD, et al. Quantitative susceptibility mapping-based cerebral metabolic rate of oxygen mapping with minimum local variance. Magn Reson Med2018; 79: 172–179.
59.
ZhangJZhouDNguyenTD, et al. Cerebral metabolic rate of oxygen (CMRO2) mapping with hyperventilation challenge using quantitative susceptibility mapping (QSM). Magn Reson Med2017; 77: 1762–1773.
60.
YablonskiyDAHaackeEM.Theory of NMR signal behavior in magnetically inhomogeneous tissues: the static dephasing regime. Magn Reson Med1994; 32: 749–763.
61.
UlrichXYablonskiyDA.Separation of cellular and BOLD contributions to T2* signal relaxation. Magn Reson Med2016; 75: 606–615.
62.
HeXYablonskiyDA.Quantitative BOLD: mapping of human cerebral deoxygenated blood volume and oxygen extraction fraction: default state. Magn Reson Med2007; 57: 115–126.
63.
RudinLIOsherSFatemiE.Nonlinear total variation based noise removal algorithms. Physica D: Nonlinear Phenom1992; 60: 259–268.
64.
NguyenTDDehKMonohanE, et al. Feasibility and reproducibility of whole brain myelin water mapping in 4 minutes using fast acquisition with spiral trajectory and adiabatic T2prep (FAST-T2) at 3 T. Magn Reson Med2016; 76: 456–465.
65.
PongratzVSchmidtPBussasM, et al. Prognostic value of white matter lesion shrinking in early multiple sclerosis: an intuitive or naïve notion?Brain Behav2019; 9: e01417.
66.
MontiLMorbidelliLRossiA.Impaired cerebral perfusion in multiple sclerosis: relevance of endothelial factors. Biomark Insights2018; 13: 1177271918774800.
67.
LauleCKozlowskiPLeungE, et al. Myelin water imaging of multiple sclerosis at 7 T: correlations with histopathology. Neuroimage2008; 40: 1575–1580.
68.
McCrearyCRBjarnasonTASkiharV, et al. Multiexponential T2 and magnetization transfer MRI of demyelination and remyelination in murine spinal cord. Neuroimage2009; 45: 1173–1182.
69.
VargasWSMonohanEPandyaS, et al. Measuring longitudinal myelin water fraction in new multiple sclerosis lesions. Neuroimage Clin2015; 9: 369–375.
70.
OtaMSatoNNakataY, et al. Abnormalities of cerebral blood flow in multiple sclerosis: a pseudocontinuous arterial spin labeling MRI study. Magn Reson Imaging2013; 31: 990–995.
71.
DuryRJFalahYGowlandPA, et al. Ultra-high-field arterial spin labelling MRI for non-contrast assessment of cortical lesion perfusion in multiple sclerosis. Eur Radiol2019; 29: 2027–2033.
72.
LawMSaindaneAMGeY, et al. Microvascular abnormality in relapsing-remitting multiple sclerosis: perfusion MR imaging findings in normal-appearing white matter. Radiology2004; 231: 645–652.
73.
GeYLawMJohnsonG, et al. Dynamic susceptibility contrast perfusion MR imaging of multiple sclerosis lesions: characterizing hemodynamic impairment and inflammatory activity. Am J Neuroradiol2005; 26: 1539–1547.
74.
AdhyaSJohnsonGHerbertJ, et al. Pattern of hemodynamic impairment in multiple sclerosis: dynamic susceptibility contrast perfusion MR imaging at 3.0 T. Neuroimage2006; 33: 1029–1035.
75.
SowaPBjørnerudANygaardGO, et al. Reduced perfusion in white matter lesions in multiple sclerosis. Eur J Radiol2015; 84: 2605–2612.
76.
IngleseMAdhyaSJohnsonG, et al. Perfusion magnetic resonance imaging correlates of neuropsychological impairment in multiple sclerosis. J Cereb Blood Flow Metab2008; 28: 164–171.
77.
BrooksDLeendersKHeadG, et al. Studies on regional cerebral oxygen utilisation and cognitive function in multiple sclerosis. J Neurol Neurosurg Psychiatry1984; 47: 1182–1191.
78.
SunXTanakaMKondoS, et al. Clinical significance of reduced cerebral metabolism in multiple sclerosis: a combined PET and MRI study. Ann Nucl Med1998; 12: 89–94.
79.
BuxtonR.Interpreting oxygenation-based neuroimaging signals: the importance and the challenge of understanding brain oxygen metabolism. Front Neuroenergetics2010; 2: 1648.
80.
LazzarottoAHamzaouiMToniettoM, et al. Time is myelin: early cortical myelin repair prevents atrophy and clinical progression in multiple sclerosis. Brain2024; 147: 1331–1343.
81.
KitzlerHHWahlHKuntkeP, et al. Exploring in vivo lesion myelination dynamics: longitudinal myelin water imaging in early multiple sclerosis. Neuroimage Clin2022; 36: 103192.
82.
PataniRBalaratnamMVoraA, et al. Remyelination can be extensive in multiple sclerosis despite a long disease course. Neuropathol Appl Neurobiol2007; 33: 277–287.
83.
NakaharaJKanekuraKNawaM, et al. Abnormal expression of TIP30 and arrested nucleocytoplasmic transport within oligodendrocyte precursor cells in multiple sclerosis. J Clin Invest2009; 119: 169–181.
84.
PodbielskaMBanikNLKurowskaE, et al. Myelin recovery in multiple sclerosis: the challenge of remyelination. Brain Sci2013; 3: 1282–1324.
85.
NeumannBSegelMChalutKJ, et al. Remyelination and ageing: reversing the ravages of time. Mult Scler2019; 25: 1835–1841.
86.
ChandlerHLSticklandRCPatitucciE, et al. Reduced brain oxygen metabolism in patients with multiple sclerosis: evidence from dual-calibrated functional MRI. J Cereb Blood Flow Metab2023; 43: 115–128.
87.
GeYZhangZLuH, et al. Characterizing brain oxygen metabolism in patients with multiple sclerosis with T2-relaxation-under-spin-tagging MRI. J Cereb Blood Flow Metab2012; 32: 403–412.
88.
ChenJTCollinsDLAtkinsHL, et al. Magnetization transfer ratio evolution with demyelination and remyelination in multiple sclerosis lesions. Ann Neurol2008; 63: 254–262.
89.
VavasourIMLauleCLiDKB, et al. Longitudinal changes in myelin water fraction in two MS patients with active disease. J Neurol Sci2009; 276: 49–53.
90.
PrineasJWKwonEEGoldenbergPZ, et al. Multiple sclerosis. Oligodendrocyte proliferation and differentiation in fresh lesions. Lab Invest1989; 61: 489–503.
91.
OzawaKSuchanekGBreitschopfH, et al. Patterns of oligodendroglia pathology in multiple sclerosis. Brain1994; 117: 1311–1322.
92.
KerschensteinerMGallmeierEBehrensL, et al. Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation?J Exp Med1999; 189: 865–870.
93.
ZajicekJPWingMScoldingNJ, et al. Interactions between oligodendrocytes and microglia: a major role for complement and tumour necrosis factor in oligodendrocyte adherence and killing. Brain1992; 115: 1611–1631.
94.
MerrillJEIgnarroLJShermanMP, et al. Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J Immunol1993; 151: 2132–2141.
95.
ColtonCAGilbertDL.Microglia, an in vivo source of reactive oxygen species in the brain. Adv Neurol1993; 59: 321–326.
96.
LeeNJHaS-KSatiP, et al. Potential role of iron in repair of inflammatory demyelinating lesions. J Clin Invest2019; 129: 4365–4376.
97.
CheliVTCorrealeJPaezPM, et al. Iron metabolism in oligodendrocytes and astrocytes, implications for myelination and remyelination. ASN Neuro2020; 12: 1759091420962681.
98.
DimovAVNguyenTDGillenKM, et al. Susceptibility source separation from gradient echo data using magnitude decay modeling. J Neuroimaging2022; 32: 852–859.
99.
LauleCVavasourIMMooreGRW, et al. Water content and myelin water fraction in multiple sclerosis. J Neurol2004; 251: 284–293.
